关键词:肝细胞瘤;栓塞,治疗性;双介入疗法
【摘要】 目的 评价CT导引双介入疗法治疗肝癌的效果。方法 150例肝癌患者中64例行单纯经导管肝动脉内含碘化油明胶海绵化疗栓塞术(LpGsTAE),86例行CT导引双介入治疗(CT-DIT),即指经皮肝肿瘤内无水乙醇注射(PEI)和LpGsTAE方法的联合应用。观察两组的疗效和生存率。结果 CT-DIT组完全缓解率为62.8%,LpGsTAE组为37.5%,CT-DIT组疗效优于LpGsTAE组;两组病死率比较,CT-DIT组低于LpGsTAE组,差异有极显著意义。结论 采用LpGsTAE治疗肝癌有一定局限性,而采用CT-DIT治疗可弥补其不足。尤其对于不能手术的肝癌,CT-DIT是一种安全有效的方法。
CT-guided double intervention therapy in thetreatment of hepatocarcinoma Zheng Jiasheng, Cui Xiongwei, Gao Yan, et al. Department of Interventional Radiology, BeijingEmergency Medical Center. Beijing 100031
【Abstract 】 Objective Toevaluate the effectiveness of treating hepatocarcinoma with CT-guided double interventiontherapy (CT-DIT). Methods 64 casesof hepatocarcinoma were treated with transcatheter hepatic artery lipiodol and gelfoamchemoembolization (LpGsTAE), 86 cases of hepatocarcinoma were treated with CT-guidedpercutaneous absolute ethyl alcohol injection (PEI) as well as transcatheter hepaticartery lipiodol and gelfoam chemoembolization (CT-DIT). The therapeutic effectiveness andsurvival rate were observed. Results The rate of complete remission was 62.8% in the CT-DIT group, whileit was 37.5% in the LpGsTAE group. CT-DIT is more effective than LpGsTAE (P<0.01). Thefatality rate in the CT-DIT group was lower than that in the LpGsTAE group, withsignificant difference between the two groups. Conclusion The treatment therapy of hepatocarcinoma with LpGsTAE has itslimitation circumscription. CT-DIT can cover the deficit of either LpGsTAE or PEI alone.So it is an effective and safe method for treating hepatocarcinoma that cannot be excised.
......
您现在查看是摘要页,全文长 22074 字符。